[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367308-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367308-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","clinicopathological-characteristics-and-the-relationship-of-pd-l1-status-tumor-mutation-burden-and-microsatellite-instability-in-patients-with-esophageal-carcinoma","Clinicopathological characteristics and the relationship of PD-L1 status, tumor mutation burden, and microsatellite instability in patients with esophageal carcinoma","","Background: Despite recent progress in immunotherapy for esophageal cancer, only a minority of patients respond and reliable predictive biomarkers remain limited. This study examined correlations among PD-L1, tumor mutational burden (TMB), and microsatellite instability (MSI) in esophageal carcinoma. Methods: One hundred ESCC tumor samples were analyzed by next-generation sequencing and immunohistochemistry; TMB was calculated and MSI evaluated with multiplex PCR. Results: PD-L1 positivity and high TMB were common, while MSI-H was rare; PD-L1 did not associate with TMB, though both related to clinical features. Conclusions: TMB and PD-L1 may support early screening biomarkers, but their statistical relationship is not evident.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinicopathological-characteristics-and-the-relationship-of-pd-l1-status-tumor-mutation-burden-and-microsatellite-instability-in-patients-with-esophageal-carcinoma/367308/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinicopathological-characteristics-and-the-relationship-of-pd-l1-status-tumor-mutation-burden-and-microsatellite-instability-in-patients-with-esophageal-carcinoma/367308.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biomarkers were studied in patients with esophageal carcinoma?","Question",{"text":63,"@type":64},"The study focused on PD-L1 status, tumor mutational burden (TMB), and microsatellite instability (MSI) as immunotherapy-related biomarkers.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were PD-L1, TMB, and MSI assessed in the ESCC samples?",{"text":68,"@type":64},"PD-L1 expression was measured using immunohistochemical analysis. TMB was calculated from mutations identified by next-generation sequencing, and MSI status was evaluated using multiplex PCR targeting five loci.",{"name":70,"@type":61,"acceptedAnswer":71},"Did PD-L1 expression correlate with TMB levels?",{"text":72,"@type":64},"No statistical association was found between PD-L1 expression levels and TMB in the ESCC cohort.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367308,1790210993,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":115,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Li etal. BMC Cancer (2025) 25:576 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-13938-y](https://doi.org/10.1186/s12885-025-13938-y)  \nRESEARCH Open Access  \nClinicopathological characteristics and the  relationship of PD-L1 status, tumor mutation burden, and microsatellite instability  \nin patients with esophageal carcinoma  \nSuyao Li 1, Yongling Yu 1, Yirong Xu2, Yue Zhou3, Junxing Huang4* and Jinghao Jia 1*  \nAbstract  \nBackground Despite significant advancements in the field of immunotherapy for esophageal cancer in recent years, only a minority of patients respond to these treatments, and effective predictive biomarkers remain elusive. Biomarkers such as programmed cell death 1 ligand 1 (PD-L1), tumor mutational burden (TMB), and microsatellite instability (MSI) are pivotal in guiding immune checkpoint inhibitor therapies. This study aimed to explore the correlation between the three biomarkers in patients with esophageal carcinoma.  \nMethods We collected one hundred esophageal squamous cell carcinoma (ESCC) tumor samples from patients who have been undergoing radical resection of esophageal carcinoma. Each tissue sample was divided into two parts for next-generation sequencing (NGS) and immunohistochemical staining. Mutations were identified using the NGS database, and TMB was calculated. Multiplex PCR targeting five loci (NR21, NR24, NR27, BAT25, and BAT26) was used to evaluate MSI. PD-L1 expression was determined through immunohistochemical analysis.  \nResults Among the 100 ESCC patients, 54%(54/100) exhibited positive PD-L1 expression, 57%(57/100) demonstrated high TMB (TMB-H), and only 1%(1/100) had high MSI (MSI-H) . Within the subset of TMB-H cases, 32 showed positive PD-L1 expression, with a single case displaying high expression of all three biomarkers, and 21 cases displaying low expression of all three biomarkers. There was no statistical association between PD-L1 expression levels and TMB. Further analysis showed a significant correlation between TNM staging and PD-L1 expression level s in ESCC tissues, with higher positive rates of PD-L1 expression observed in advanced stages. Similarly, a significant relationship was observed between TMB and lymph node metastasis.  \nConclusions Based on our preliminary results, TMB and PD-L1 can serve as potential early screening clinical biomarkers and molecular targets for immune treatment in ESCC. However, there is no apparent statistical association between TMB and PD-L1 expression levels. Furthermore, PD-L1 and TMB may independently influence the efficacy  \n*Correspondence: Junxing Huang [obli46@163.com](obli46@163.com)[ ](obli46@163.com)Jinghao Jia[r3ku33@163.com](r3ku33@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nLi et al. BMC Cancer (2025) 25:576 Page 2 of 9  \nof immunotherapy, highlighting the inadequacy of single-marker detection in effectively predicting treat","cbCainRSm6O6w9Ee","https://ap.wps.com/l/cbCainRSm6O6w9Ee","pdf",1571213,"English","# Abstract\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Introduction\n## PD-L1 and immunotherapy\n## TMB and immunotherapy\n## MSI and clinical relevance","[{\"question\":\"What biomarkers were studied in patients with esophageal carcinoma?\",\"answer\":\"The study focused on PD-L1 status, tumor mutational burden (TMB), and microsatellite instability (MSI) as immunotherapy-related biomarkers.\"},{\"question\":\"How were PD-L1, TMB, and MSI assessed in the ESCC samples?\",\"answer\":\"PD-L1 expression was measured using immunohistochemical analysis. TMB was calculated from mutations identified by next-generation sequencing, and MSI status was evaluated using multiplex PCR targeting five loci.\"},{\"question\":\"Did PD-L1 expression correlate with TMB levels?\",\"answer\":\"No statistical association was found between PD-L1 expression levels and TMB in the ESCC cohort.\"}]","Clinicopathological characteristics and the relationship of PD-L1 status, tumor mutation burden, and microsatellite instability in patients with esophageal carcinoma | PDF",1790170175,23,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aee019857c82c48c3975daa3d1b7bf82.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f846d92b91f47a6ef57ee40f62a6dd77.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba2956a05923bee5db8ec219af814041.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0bf5633803904aef1fd079fe8b1a101.webp",980,1306]